Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| 8-Phenyl-2,6-dibromo-1,3,5,7-tetramethyl BODIPY | C19H17BBr2F2N2 | 910823-84-6 | Details |
| (R)-BI-2852 | C31 H28 N6 O2 | 2375482-49-6 | Details |
| 7-Ketocholesterol | C27H44O2 | 566-28-9 | Details |
| 16-phenoxy tetranor Prostaglandin F2α | C22H30O6 | 51705-19-2 | Details |
| PU23 | C21H19N3O3S2 | 817635-93-1 | Details |
| GPAT-IN-1 | C21H26ClNO4S | 1204347-51-2 | Details |
| TGFβ1-IN-3 | 2883813-58-7 | Details |
| (Z)-SU14813 | C23H27FN4O4 | 452105-23-6 | Details |
| Etanercept | H4NO3V | 185243-69-0 | Details |
| LYS006 hydrochloride (1799681-85-8 Free base) | Details |
| Meclizine | C25H27ClN2 | 569-65-3 | Details |
| STING Agonist 12b | C16H15NO2 | 2411100-70-2 | Details |
| GSK321 | C28H28FN5O3 | 1816331-63-1 | Details |
| Tiragolumab | 1918185-84-8 | Details |
| Camelliaside A | C33H40O20 | 135095-52-2 | Details |
| physalin F | C28H30O10 | 57423-71-9 | Details |
| (±)14(15)-EpETE | C20H30O3 | 131339-24-7 | Details |
| CRK12-IN-1 | C20H26F2N4O3S2 | 1990479-14-5 | Details |
| Mespirenone | C25H30O4S | 87952-98-5 | Details |
| (S)-OSMI 3 | 2411972-78-4 | Details |
| CAY10727 | C21H22Cl2N4O2 | 1671088-84-8 | Details |
| CRA-026440 hydrochloride | C23H25ClN4O4 | 847459-98-7 | Details |
| USP8-IN-3 | C18H18F3N5O2S | 2477651-10-6 | Details |
| DI-N-OCTYL PHTHALATE | C24H38O4 | 117-84-0 | Details |
| Suptavumab | 1629615-23-1 | Details |
| Lodoxamide ethyl | C15H14ClN3O6 | 53882-13-6 | Details |
| TMPH | C16H31NO2 | 849461-90-1 | Details |
| 10-hydroxy Warfarin | C19H16O5 | 83219-99-2 | Details |
| AP-III-a4 | C31H43FN8O3 | 1177827-73-4 | Details |
| RNase L-IN-2 | C16H14N2O2S | 357618-26-9 | Details |
| S 38093 HCl | C17H25ClN2O2 | 1222097-72-4 | Details |
| Stictic Acid | C19H14O9 | 549-06-4 | Details |
| PDL-1 cpd 10 | C21H23N5O2 | 2767424-13-3 | Details |
| Rimtuzalcap | C18H24F2N6O | 2167246-24-2 | Details |
| N-benzyl-heptadecanamide | C24H41NO | 883715-19-3 | Details |
| Novokinin acetate | Details |
| MKC-1 | C22H16N4O4 | 125313-92-0 | Details |
| Rilotumumab | 872514-65-3 | Details |
| CPX-351 | 1256639-86-7 | Details |
| P 218 | C18H25ClN4O4 | 1142407-60-0 | Details |
| LY2880070 | C19H23N7O2 | 1375637-35-6 | Details |
| p38 MAP Kinase Inhibitor IV | C12H4Cl6O4S | 1638-41-1 | Details |
| Dodecamethylpentasiloxane | C12H36O4Si5 | 141-63-9 | Details |
| Cyclo(Tyr-Leu) | C15H20N2O3 | 82863-65-8 | Details |
| Loganetin | C11H16O5 | 29748-10-5 | Details |
| uk-50001 | C26H24F3N3O4 | 857900-47-1 | Details |
| Leukotriene B4 Ethanolamide | C22H37NO4 | 877459-63-7 | Details |
| 5(S),12(S)-DiHETE | C20H32O4 | 79056-01-2 | Details |
| VK-II-36 | C26H26N2O5 | 955371-66-1 | Details |
| Dihexyl carbonate | C13H26O3 | 7523-15-1 | Details |
| Fluorescein Sodium | C20H13NaO5 | 518-47-8 | Details |
| KN1022 | C21H22N6O5 | 205255-11-4 | Details |
| TNF/IFNγ-IN-1 | C20H23N3O6 | 876013-29-5 | Details |
| 9-Ethylguanine | C7H9N5O | 879-08-3 | Details |
| Kamuvudine-8 | Details |
| Dup-721 | C14H16N2O4 | 104421-21-8 | Details |
| Teduglutide acetate | C164H252N44O55S | 287714-30-1 | Details |
| Emodinanthrone | C15H12O4 | 491-60-1 | Details |
| Guselkumab | 1350289-85-8 | Details |
| DENV-IN-5 | C23H25ClF2N4OS | 2375781-06-7 | Details |
| 17-Epiestriol | C18H24O3 | 1228-72-4 | Details |
| IMP-1088 | C25H29F2N5O | 2059148-82-0 | Details |
| Lactoferrin | 936541-36-5 | Details |
| Resolvin D2 methyl ester | C23H34O5 | 810668-53-2 | Details |
| 4BP-TQS | C18H17BrN2O2S | 360791-49-7 | Details |
| Tomatidine | C27H45NO2 | 77-59-8 | Details |
| Z944 | C19H27ClFN3O2 | 1199236-64-0 | Details |
| VH 032 Linker 3 (hydrate) | Details |
| Daclizumab | 152923-56-3 | Details |
| 6,7-DIMETHOXY-3,4-DIHYDRO-2H-ISOQUINOLIN | C11H13NO3 | 493-49-2 | Details |
| β-Endorphin (1-27) (human) acetate | Details |
| Duvelisib (R enantiomer) hydrochloride | Details |
| CDP-Star | C18H19Cl2Na2O7P | 160081-62-9 | Details |
| ITF3756 | C13H11N5O2S | 2247608-27-9 | Details |
| RP-6306 | C18H20N4O2 | 2719793-90-3 | Details |
| WAY-640509 | C25H23N5O4S | 851185-20-1 | Details |
| EPZ032597 | C20H23N7O | 1887193-58-9 | Details |
| PF-9363 | C20H20N4O6S | 2569009-58-9 | Details |
| SW106065 | C10H8N2OS | 62289-81-0 | Details |
| Octahydrocurcumin | C21H28O6 | 36062-07-4 | Details |
| ACETOXYVALERENIC ACID | C17H24O4 | 84638-55-1 | Details |
| 10-Norparvulenone | C12H14O5 | 618104-32-8 | Details |
| IL-18BP Protein, Human, Recombinant (aa 1-192, hFc) | Details |
| POV-PC | C29H56NO9P | 121324-31-0 | Details |
| Emicizumab | 1610943-06-0 | Details |
| FAK-IN-15 | Details |
| UC2288 | C20H18ClF6N3O2 | 1394011-91-6 | Details |
| Malabaricone A | C21H26O3 | 63335-23-9 | Details |
| Poly-D-lysine hydrobromide (MW 30000-70000) | C6H14N2O2 | 27964-99-4 | Details |
| Afimetoran | C26H32N6O | 2171019-55-7 | Details |
| Thrombospondin-1 (1016-1023) (human, bovine, mouse) | C56H81N13O10S | 149234-04-8 | Details |
| Cinepazet | C20H28N2O6 | 23887-41-4 | Details |
| p-MPPF | C25H27FN4O2 | 155204-26-5 | Details |
| Raxofelast | C15H18O5 | 128232-14-4 | Details |
| HFY-4A | C20H19N3O2 | 2094810-82-7 | Details |
| pNPS-DHA | C28H36N2O5S | 2454246-25-2 | Details |
| Premarin | C18H22O5S | 481-97-0 | Details |
| SIRT7 inhibitor 97491 | C15H12ClN3O | 1807758-81-1 | Details |
| BTA-188 | C21H28N4O2 | 314062-80-1 | Details |
| N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide | C27H45NO3 | 1258011-97-0 | Details |
| Product Total： Product Page： | ||||
| 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 | ||||